Lv1
90 积分 2022-12-08 加入
Intermediate Uveitis: A Review
10天前
已关闭
Uveitis in Adults: A Review
10天前
已完结
Effects of Prostaglandin F2α on Adipocyte Biology Relevant to Graves' Orbitopathy
13天前
已完结
Targeting TSH and IGF-1 Receptors to Treat Thyroid Eye Disease
14天前
已完结
Teprotumumab for patients with active thyroid eye disease: a pooled data analysis, subgroup analyses, and off-treatment follow-up results from two randomised, double-masked, placebo-controlled, multicentre trials
14天前
已完结
The Rate of Re-treatment in Patients Treated with Teprotumumab: A Multicenter Study of 119 Patients with 1 Year of Follow-up
14天前
已完结
Graves disease: latest understanding of pathogenesis and treatment options
14天前
已完结
IGF-1R Inhibitor IBI311 for the Treatment of Active Thyroid Eye Disease in Chinese Patients: The RESTORE-1 Randomized Clinical Trial
14天前
已完结
A small molecule antagonist inhibits thyrotropin receptor antibody-induced orbital fibroblast functions involved in the pathogenesis of Graves ophthalmopathy
14天前
已完结
皖公网安备34019202002308
